Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection?

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Lola Rahib, Benjamin D. Smith, Rhonda Aizenberg et al. · Cancer Research · 2014 · 7.1K citations

Top Cancer, Surgical Oncology, Cancer Management +22

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Surgical Oncology, Oncology, Pancreatic Cancer +6

Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma

Vincent P. Groot, Neda Rezaee, Wenchuan Wu et al. · Annals of Surgery · 2017 · 706 citations

Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer

Ryan P. Merkow, Karl Y. Bilimoria, James S. Tomlinson et al. · Annals of Surgery · 2013 · 426 citations

Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma

Vincent P. Groot, Georgios Gemenetzis, Alex B. Blair et al. · Annals of Surgery · 2018 · 364 citations